Cardiovascular Protection against Chemotherapeutics and Environmental Toxins: New Agents and Molecular Targets
A special issue of Diseases (ISSN 2079-9721). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 5169
Special Issue Editors
Interests: cardiovascular pharmacology; cardio-Oncology; molecular medicine
Special Issues, Collections and Topics in MDPI journals
2. Institute for Chemistry, Humboldt Universität zu Berlin, Brook-Taylor-Str. 2, 12489 Berlin, Germany
Interests: synthetic organic chemistry; synthetic medicinal chemistry; stereochemistry; Heterocyclic Chemistry; drug synthesis and development; small molecule drug discovery by high-throughput library screening; computer aided drug design (modelling, virtual screening); chemistry of lipids; role of lipids in human diseases; development of biochemical tools to study structure and function of lipids; development of enzymatic assays
Special Issues, Collections and Topics in MDPI journals
Interests: cardiology; cardio-oncology; cardiac imaging
Special Issues, Collections and Topics in MDPI journals
Interests: ischemia/reperfusion injury; myocardial infarction; cardiomyopathy
Special Issues, Collections and Topics in MDPI journals
Interests: pharmacology; drug toxicology; alternative medicine; environmental pharmacology and toxicology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The characterization, management, and prevention of cardiotoxicity, whether caused by pharmacological agents (cardiovascular and non-cardiovascular) or environmental exposures, compose a growing area of research. Cancer chemotherapeutics, in particular, have multiple off-target effects on the cardiovascular system, and studying these effects has led to the birth of the new cardio-oncology field. This Special Issue aims to present the latest advances in the study of cardiotoxicity and especially the field of cardio-oncology, in order to better understand the underlying mechanisms and improve the cardiac safety of therapeutic interventions. Potential topics include, but are not limited to:
- Cardiac effects, molecular mechanisms, and signaling pathways of drugs, xenobiotics, and environmental toxins
- Cardiovascular effects of classic cancer chemotherapeutics (e.g., anthracyclines) and new agents (e.g., immune checkpoint inhibitors)
- Safety and efficacy of novel cardioprotective agents against cardiotoxicity
- Development and validation of in vivo and in vitro models to study cardiotoxicity
You may choose our Joint Special Issue in Molecules.
Dr. Abdelrahman I. Abushouk
Dr. Essa Saied
Dr. Kartik Anand
Dr. Anas Saad
Dr. Mohamed M. Abdel-Daim
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diseases is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiotoxicity
- cardioprotection
- cardio-oncology
- cardiovascular pharmacology
- molecular cardiology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
